SC 13D/A | 2019-02-25 | ARES MANAGEMENT LLC | BioScrip, Inc. | 11,688,866 | 8.8% | EDGAR |
SC 13G/A | 2019-02-15 | GILDER GAGNON HOWE & CO LLC | BioScrip, Inc. | 15,653,966 | 12.2% | EDGAR |
SC 13G/A | 2019-02-14 | Venor Capital Management LP | BioScrip, Inc. | 12,855,619 | 10.0% | EDGAR |
SC 13G/A | 2019-02-14 | GILDER GAGNON HOWE & CO LLC | BioScrip, Inc. | 15,653,966 | 12.2% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | BioScrip, Inc. | 9,807,734 | 7.6% | EDGAR |
SC 13D/A | 2019-01-03 | Coliseum Capital Management, LLC | BioScrip, Inc. | 24,130,114 | 16.1% | EDGAR |
SC 13D/A | 2018-11-27 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 8,024,220 | 6.3% | EDGAR |
SC 13D/A | 2018-08-13 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 9,283,630 | 7.2% | EDGAR |
SC 13G/A | 2018-02-14 | Venor Capital Management LP | BioScrip, Inc. | 14,207,992 | 11.1% | EDGAR |
SC 13G/A | 2018-02-14 | GILDER GAGNON HOWE & CO LLC | BioScrip, Inc. | 15,625,055 | 12.2% | EDGAR |
SC 13G/A | 2018-02-14 | Camber Capital Management LLC | BioScrip, Inc. | - | - | EDGAR |
SC 13G/A | 2018-02-01 | NORTH TIDE CAPITAL, LLC | BioScrip, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2018-02-01 | BlackRock Inc. | BioScrip, Inc. | 6,584,105 | 5.2% | EDGAR |
SC 13G/A | 2018-01-26 | ARDSLEY ADVISORY PARTNERS | BioScrip, Inc. | 90,000 | 0.1% | EDGAR |
SC 13G/A | 2017-11-07 | Venor Capital Management LP | BioScrip, Inc. | 13,162,022 | 10.3% | EDGAR |
SC 13D/A | 2017-09-08 | Coliseum Capital Management, LLC | BioScrip, Inc. | 21,514,620 | 14.6% | EDGAR |
SC 13D/A | 2017-08-18 | Coliseum Capital Management, LLC | BioScrip, Inc. | 24,208,030 | 16.5% | EDGAR |
SC 13D/A | 2017-08-11 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 10,228,742 | 8.0% | EDGAR |
SC 13D/A | 2017-07-13 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 10,758,742 | 8.9% | EDGAR |
SC 13D | 2017-07-10 | ARES MANAGEMENT LLC | BioScrip, Inc. | 10,767,555 | 8.2% | EDGAR |